Cancer Gene Therapy Market - Forecasts From 2018 To 2023

Description

The cancer gene therapy market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. A type of experimental treatment in which foreign genetic material (DNA or RNA) is inserted into a person's cells to prevent or fight disease. Gene therapy is being studied in the treatment of certain types of cancer (source: National Cancer Institute, National Institutes of Health). The growing incidence and prevalence of cancer worldwide are emanating the demand for the cancer gene therapy fuelling the market growth. Research and Innovations in the treatment of cancer are also driving the growth of the global cancer gene therapy market in the forecast period.

An analysis of health claims data from two demographically similar regions on either side of the U.S. and Canada border shows that a common treatment for advanced colorectal cancer costs twice as much in Western Washington State (WW) than in British Columbia (BC) -- $12,345 vs. $6,195 monthly per patient. Despite the higher cost, the patients on the U.S. side of the border are not living longer than those on the Canadian side (source: American Society of Clinical Oncology, ASCO). Thus, the high cost of cancer treatment is a major factor restraining the market growth in the forecast period.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the cancer gene therapy value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the cancer gene therapy market.

Major industry players profiled as part of the report are Achilles Therapeutics Limited, Adaptimmune Therapeutics plc, American Gene Technologies Inc., Moderna, Inc. and Autolus Therapeutics plc among others.

Segmentation

The cancer gene therapy market has been analyzed through following segments:

By Type

Gene Transfer

Genetically Engineered Viruses

Immunotherapy

Others

By End User

Hospitals

Clinical Research Organisations

Biotech Companies

Research Institutes

By Geography

North America

USA

Canada

Mexico

Others

South America

Brazil

Argentina

Others

Europe

Germany

France

United Kingdom

Spain

Others

Middle East and Africa

Saudi Arabia

Israel

Others

Asia Pacific

China

Japan

South Korea

India

Others

Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants

Key insights offered

What will be the cancer gene therapy market size from 2017 to 2023?

How are the major drivers and restraints affecting the cancer gene therapy market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.